GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links.

007 No Time To Die Tickets Now On Sale In The US

Tickets for Daniel Craig's final Bond movie, which has been delayed time and again, are now on sale.


After many delays, the new James Bond movie, No Time To Die, finally releases this October in the United States. With the premiere date approaching, tickets for the action film have gone on sale at ticket-sellers and directly from theaters.

You can now purchase tickets for No Time To Die through Fandango and Atom for showings that begin with preview screenings on October 7 ahead of the movie's official release on Friday, October 8. Tickets are also on sale through

No Time To Die was originally slated for release in theaters in April 2020, but it became one of the first major blockbusters to get delayed due to the onset of the pandemic.

The producers reportedly considered bringing No Time To Die to a streaming service, but MGM is said to have asked for a $600 million payment, and no one bit. The movie's theatrical release date shifted a few more times before finally settling on October 8 in the US. As is customary for the 007 series, No Time To Die will release first in the UK, coming to cinemas there on September 30.

True Detective's Cary Joji Fukunaga directed No Time To Die, which is the first Bond movie ever to be shot with Imax 15/70 cameras, according to Deadline. It's also the first to be shown in 3D and RealD formats. Additionally, you can book a ticket to see No Time To Die in ScreenX, which is a massive 270-degree screen. There is a 4DX version, too, which uses a variety of physical effects like motion, wind, and smells.

No Time To Die is Daniel Craig's fifth and final 007 movie, with a new actor coming in to play the British superspy when the series inevitably continues in the future. This next Bond movie will be the first under Amazon, which acquired MGM for $8.45 billion earlier this year.

Got a news tip or want to contact us directly? Email

Join the conversation
There are no comments about this story